APA (7th ed.) Citation

SV, J., & NS, R. (2015). Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies? Hepatic medicine : evidence and research, 7, 11. https://doi.org/10.2147/HMER.S79584

Chicago Style (17th ed.) Citation

SV, Janardhan, and Reau NS. "Should NS5A Inhibitors Serve as the Scaffold for All-oral Anti-HCV Combination Therapies?" Hepatic Medicine : Evidence and Research 7 (2015): 11. https://doi.org/10.2147/HMER.S79584.

MLA (9th ed.) Citation

SV, Janardhan, and Reau NS. "Should NS5A Inhibitors Serve as the Scaffold for All-oral Anti-HCV Combination Therapies?" Hepatic Medicine : Evidence and Research, vol. 7, 2015, p. 11, https://doi.org/10.2147/HMER.S79584.